Rock Creek Pharmaceuticals Announces Presentation Of Four Anatabine Projects At Neuroscience 2014

By: via Benzinga
Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.